Artificial Intelligence

Fintech leader MeridianLink hires former Genesys and Permira exec Raj Patel as CTO, signaling a major push into AI-driven digital lending platforms.

A new modular AI accelerator plugs into any Thunderbolt laptop, promising to bring powerful generative AI development to the masses, free from the cloud.

With backing from major publishers, a new auction environment aims to tackle programmatic advertising's notorious opacity and reshape the digital media supply chain.

A new AI-powered system unveiled at CES 2026 promises to grow personalized, nutrient-optimized microgreens right on your countertop.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?

Registration is open for the 2026 Connect Summit, a key event uniting tech, policy, and healthcare leaders to tackle social care challenges.

The sale of kACE Financial for up to $119 million marks a strategic pivot for BGC and a power play by smartTrade in the competitive FX tech space.

With top pediatrician Dr. Carol Weitzman on board, EyeContactDX aims to bring its AI-powered ASD screening tool to primary care, promising faster, more equitable diagnosis.

At CES 2026, Water Robotics debuts CAMA, a bed that uses AI and thousands of sensors to physically adapt to your body, ushering in a new era of sleep.

Segway moves beyond scooters with new intelligent e-bikes and dirt bikes for North America, betting its connected tech ecosystem can disrupt a booming market.

With its lead muscular dystrophy drug in late-stage trials, Edgewise Therapeutics heads to the JPM conference with high stakes for its pipeline and stock.

Keysight Technologies taps Applied Materials veteran Liz Morali to lead investor relations, a strategic move to bolster market confidence and articulate its complex growth story.

TCS's new Digital Twindex report outlines a future of intelligent, learning vehicles. But the road from hype to reality is paved with challenges.

A new antibody-drug conjugate, DEM301, shows preclinical promise by targeting a unique protein to directly kill tumors and unleash the immune system.

The garage door giant enters the smart home fray with an AI-powered device combining a lock, camera, and doorbell, challenging Ring and others.

With its first drug for a rare disease now on the market, Stealth BioTherapeutics bets its future on a deep pipeline targeting mitochondrial dysfunction.

Newcomer Candid Therapeutics is set to unveil its T-cell engager platform at J.P. Morgan, a move that could shake up the autoimmune treatment landscape.

A Northwest Ohio jail hires Armor Health, promising AI-driven care. But the company's history of hundreds of lawsuits raises serious questions.

Mackenzie Investments' 2026 forecast warns of fewer Fed cuts than expected, highlighting opportunities in AI-driven equities and strategic commodities.

CapStone Holdings acquires decade-old AI sales platform Structurely, signaling a strategic shift towards mature, data-rich infrastructure over fleeting hype.